ICPT - Intercept Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue179,804130,95624,9512,782
Cost of Revenue2,5191,371--
Gross Profit177,285129,58524,9512,782
Operating Expenses
Research Development207,301190,199153,893112,696
Selling General and Administrative255,474269,798228,596119,242
Non Recurring----
Others----
Total Operating Expenses465,294461,368382,489231,938
Operating Income or Loss-285,490-330,412-357,538-229,156
Income from Continuing Operations
Total Other Income/Expenses Net-23,752-29,955-55,2922,727
Earnings Before Interest and Taxes-285,490-330,412-357,538-229,156
Interest Expense-30,523-29,271-14,196-14,196
Income Before Tax-309,242-360,367-412,830-226,429
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-309,242-360,367-412,830-226,429
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-309,242-360,367-412,830-226,429
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-309,242-360,367-412,830-226,429